DACPLAT
Categoria
DACPLAT Marchi, DACPLAT Analoghi
DACPLAT Marchi miscela
DACPLAT Formula chimica
DACPLAT RX link
DACPLAT FDA foglio
DACPLAT DMS (foglio di materiale di sicurezza)
DACPLAT Sintesi di riferimento
DACPLAT Peso molecolare
DACPLAT Temperatura di fusione
DACPLAT H2O Solubilita
DACPLAT Stato
DACPLAT LogP
DACPLAT Forme di dosaggio
DACPLAT Indicazione
DACPLAT Farmacologia
DACPLAT Assorbimento
DACPLAT Tossicita
DACPLAT Informazioni paziente
Patients and patientsí caregivers should be informed of the expected side effects of ELOXATIN, particularly its neurologic effects, both the acute, reversible effects, and the persistent neurosensory toxicity. Patients should be informed that the acute neurosensory toxicity may be precipitated or exacerbated by exposure to cold or cold objects. Patients should be instructed to avoid cold drinks, use of ice, and should cover exposed skin prior to exposure to cold temperature or cold objects.
Patients must be adequately informed of the risk of low blood cell counts and instructed to contact their physician immediately should fever, particularly if associated with persistent diarrhea, or evidence of infection develop.
Patients should be instructed to contact their physician if persistent vomiting, diarrhea, signs of dehydration, cough or breathing difficulties occur, or signs of allergic reaction appear.
